ArticleCell communication and signaling : CCS2026
Glucose transport dependency defines a therapeutic vulnerability in JAK2V617F-driven myeloproliferative neoplasms.
Patrick Weiand et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.